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Prevalence of human papillomavirus types 16 and
18 in penile carcinoma: a study of 41 cases using
PCR
KW Chan, K Y Lam, A C L Chan, P Lau, G Srivastava
Abstract
Aims-To determine retrospectively the
prevalence of human papillomavirus
(HPV) types 16 and 18 in penile carcino-
mas.
Methods-Forty one surgically resected
penile carcinomas from the archives at
Queen Mary Hospital, Hong Kong, were
reviewed and classified into verrucous
carcinoma, and well, moderately, and
poorly differentiated squamous cell car-
cinomas. Paraffin wax embedded tumour
tissue was sectioned and analysed for
HPV 16 and HPV 18 using the polymerase
chain reaction with type specific internal
probes.
Results-There were seven verrucous
carcinomas, and 11 well, 17 moderately,
and six poorly differentiated squamous
cell carcinomas. Six of the 41 (15%)
patients had penile carcinoma containing
HPV 16 or HPV 18 DNA, or both, with
HPV 16 found in four (10%) and HPV 18
in four (10%). The mean ages of HPV
positive and HPV negative groups of
patients were 68-5 and 57-6 years, respec-
tively (p <0.05). None of the seven verru-
cous and 11 well differentiated squamous
cell carcinomas was positive for HPV.
The mean age of patients who had these
carcinomas was 52 4 years. As a group,
these low grade carcinomas occurred in
patients younger by more than a decade
than those who had carcinomas of the
higher grades (mean age 64i4 years; p
<0.01).
Conclusions-Penile carcinomas had
much lower rates of infection by HPV 16
or HPV 18 than cervical carcinomas in
this Hong Kong population. Based on our
findings and on data collated from pub-
lished findings, it is concluded that penile
verrucous carcinomas are not associated
with HPV 16 and HPV 18. The overall low
prevalence of HPV 16 and HPV 18 in
penile carcinomas suggests that other
HPV types might be important in the
pathogenesis ofthese tumours.
(J Clin Pathol 1994;47:823-826)
Human papillomaviruses (HPV) are DNA
viruses comprising more than 60 different
types.' Specific types of HPV, most com-
monly type 16 (HPV 16) and less commonly
type 18 (HPV 18), have been implicated in
the aetiology of cervical squamous cell carci-
nomas.2 Although genital HPV infections are
sexually transmitted, information on the
association between HPV and penile carcino-
mas has seldom been collected, probably
because of the low incidence of these tumours
compared with cervical carcinomas.3
In the present study, we used the highly
sensitive and specific polymerase chain reac-
tion (PCR) to define the association between
HPV 16 and HPV 18 with penile carcinomas.
Our findings are compared with relevant data
reported in other countries and the incidence
ofHPV 16 and 18 in invasive cervical carcino-
mas of the local population. To the best of
our knowledge, this study is the first large
series of penile carcinomas in Chinese
patients examined for HPV by this highly
specific and sensitive DNA detection method.
Methods
Cases of verrucous and squamous cell carci-
noma of the penis from 1974-1992 were
retrieved from the archives of the Department
of Pathology at Queen Mary Hospital. Only
surgical specimens containing the primary
tumours were selected. The slides were
reviewed and the diagnosis confirmed by two
pathologists (KY Lam and ACL Chan). The
tumours were classified into verrucous carci-
noma, and well, moderately, and poorly dif-
ferentiated squamous cell carcinomas. The
criteria used for differentiating verrucous car-
cinoma were a densely keratinised surface and
a sharply delineated deep margin with a more
expansive margin composed of bulbous
downgrowths of well differentiated keratinis-
ing squamous epithelium.4 One representative
block from each haematoxylin and eosin
stained specimen was sectioned and subjected
to PCR analysis.
The oligonucleotide primers used in the
PCR for HPV 16 were complementary to the
upstream regulatory region of the viral DNA,5
while for HPV 18 they were complementary
to sequences in the E6 region.6 These regions
were chosen because they are almost always
retained even if the HPV DNA is integrated in
tumours. The sequences of the primers used
are shown in table 1.
In each case, a 16 ,um thick section was cut
from the paraffin wax embedded tumour tis-
sue and waxed with sequential washes of
xylene, 95% ethanol, and absolute ethanol
and then vacuum dried. The section was
resuspended in 50 ,ul of water, boiled for 20
minutes, and snap cooled on ice to release
and denature the DNA before PCR analysis.
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Table 1 Sequence of oligonucleotide pimers
HPV type Sequence (5'->3') Size ofamplified product (base pairs)
HPV16 A:AAGGCCAACTAAATG 228
TCAC (19-mers)
B: GCG GAT CCT GTC TGC
TTIT TAT ACT AA (26-mers)
Probe: TlT CGG TTCAACGCGA
TlT GCGG (21-mers)
HPV 18 A:ACCGTTAATGAAAAAC 100
GAC GA (20-mers)
B: CGT CGT TGG AGT CGT
TCC TG (20-mers)
Probe: TAG CTG GGCACT ATA
GAG GC (20-mers)
Amplification of the HPV 16 or HPV 18 tar-
geted DNA sequences was carried out for 40
cycles using a GeneAmp PCR Core Reagent
kit (Perkin Elmer Cetus, Connecticut, USA)
and programmable thermal controller (MJ
Research, Inc., Massachusetts, USA), with
37°C as the annealing temperature (for two
minutes). The amplified products were
analysed by gel electrophoresis in 4% NuSieve
3:1 agarose (FMC Bioproducts, Maine,
USA), followed by ethidium bromide stain-
ing. The specificity of the amplified product
was confirmed by Southern blotting of the gel,
followed by probing of the membrane with
32P-labelled internal probes specific for the
amplified HPV 16 or HPV 18 DNA. The
hybridisation and washing conditions were
identical with those previously reported by
our laboratory.7
DNA extracted from CaSki and HeLa cell
lines, obtained from the American Tissue
Type Culture Collection, were used as posi-
tive controls for HPV 16 and HPV 18, respec-
tively. DNA extracted from paraffin wax
sections of rat kidney was used as a negative
control in each set of PCR.
The following additional precautions were
taken to prevent possible cross-contamination
between the samples during the PCR proce-
dure: (1) sections were cut using different dis-
posable microtome blades for each sample,
and negative control blocks were cut between
the cases under study; (2) all the manipula-
tions preceding PCR analysis were performed
in a separate room away from the PCR
machine; and (3) the PCR products were
analysed in a separate room. As a positive
amplification control, primers (PCO3 and
PC04) specific for human ,B globin gene were
used in PCR analysis for all the samples stud-
ied, as described by Saiki et al,8 using 56°C as
the annealing temperature (for two minutes).
The 32P-labelled oligomeric primer RS06 was
Table 2 Penile carcinoma and HPV types 16 and 18
Squamous cell carcinoma grade of differentiation
Verrucous
carcinoma WeU Moderate Poor Total
HPV 16 positive 0 0 1 1 2
HPV 18 positive 0 0 1 1 2
HPV 16/18 positive 0 0 1 1 2
HPV 16/18 positive 7 11 14 3 35
Number of patients 7 1 1 17 6 41
Mean age (years) 52-4 64-4 59-2
used as an internal probe to confirm the speci-
ficity of the amplified product (110 base
pairs).
Statistical analysis was performed using
Fisher's exact and Student's t tests.
Results
A total of 43 patients were identified as having
verrucous or squamous cell carcinoma of the
penis in the period 1974 to 1992. The block
from one specimen showed no PCR amplifi-
cation of the fi globin gene. It was concluded
that the quality of DNA in this specimen was
poor and was thus excluded from the study.
Another specimen was excluded because
insufficient DNA was left to complete the,B
globin PCR. The results of PCR amplification
of HPV on 41 specimens were subjected to
statistical analysis.
The age of the 41 patients ranged from 29 to
84 years. The mean and median ages of the
41 patients were 59 years. The only non-
Chinese patient encountered was a 29 year
old Vietnamese man. When patients were
divided into two groups according to the his-
tological grades of their tumours with their
mean ages compared (table 2), the difference
was highly significant (p <0 01, t test).
Of the 41 tumours selected, six were posi-
tive for either HPV 16 or HPV 18, or both.
Table 2 shows the distribution ofHPV 16 and
HPV 18 in the tumours according to histolog-
ical types and grades. The six patients who
had HPV in their tumours had a mean age of
68-5 years. This was significantly higher than
the 57-6 years, the mean age of the group of
patients who had no HPV in their tumours (p
<005; t test). When the mean age of HPV
positive patients were compared with that of
HPV negative patients having the same histo-
logical grades of tumours, there was no signif-
icant difference (p >010; t test).
Discussion
Different methods have been used to detect
type specific HPV in penile carcinomas.
These include Southern blotting,910 in situ
hybridisation,4111' and PCR. 1- Among
these, PCR seems to be superior because of its
high sensitivity. Varma et a!12 recently applied
both in situ hybridisation and PCR to study
the incidence of HPV types in penile carcino-
mas. The concordance rate of the results
obtained by both techniques were high. They
found two instances of false negative results of
in situ hybridisation in resection specimens
and thought that some problems in obtaining
optimally preserved tissue in archival resec-
tion specimens were responsible. PCR was
able to detect the virus in one of the two
resection specimens which gave false negative
results by in situ hybridisation. PCR alone
was therefore chosen for the purpose of the
present study.
The prevalence of HPV in the uterine
cervix and the strong association between cer-
tain HPV types and cervical carcinomas is
well documented.'67 A recent study of 45
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invasive carcinomas of the uterine cervix per-
formed in our laboratory using the same PCR
technique7 showed that 69% and 44% of the
tumours were positive for HPV 16 and HPV
18, respectively, while 82% of the tumours
were positive for at least one of these two
types of HPV. The 10% incidence of HPV
types 16 and 18 in penile carcinomas was thus
much lower than the corresponding figures
found in cervical carcinomas in Hong Kong
(p <0'001; Fisher's exact probability test).
The findings suggested that HPV types 16
and 18 were unlikely to have a strong associa-
tion with penile carcinomas in Hong Kong,
and that the aetiological factors for penile car-
cinomas might be different from those for cer-
vical carcinomas.
Table 3 summarises the reported inci-
dences of HPV types 16 and 18 in penile car-
cinomas. The data we had listed were from
Brazil,9- 1 the USA,412 14 and Australia. "I Brazil
has a high incidence of penile carcinoma com-
pared with other countries in the world.3
Hong Kong has a low incidence of penile
squamous cell carcinoma comparable with
that in Australia and the USA. Our results
showed a generally lower incidence of HPV
16 and a slightly higher incidence of HPV 18
in penile carcinomas than those found else-
where.
In our study none of the well differentiated
or verrucous carcinomas was positive for HPV
16 or HPV 18. It is worth noting that Masih et
al' in the USA were unable to find HPV types
6, 11, 16, 18, and 31 in any of their 10 cases of
penile verrucous carcinomas. Kiyabu and col-
leagues'3 studied two and three cases of non-
verrucous and verrucous penile carcinomas,
respectively. HPV 16 was identified in the two
non-verrucous, but not in the verrucous, carci-
nomas. Their five cases were uniformly nega-
tive for HPV 18. Higgins et all" similarly could
not detect HPV in all the five verrucous carci-
nomas studied, but HPV RNA was detected
in one of eight well differentiated, and nine of
18 higher grade carcinomas, studied. There
were no examples of verrucous carcinoma in
the series of Wiener et aP4 who found one of
the four well differentiated carcinomas posi-
tive for HPV 16. Of 17 penile carcinomas of
higher grades they studied, five and one were
positive for HPV 16 and HPV 18, respec-
tively. None of the four penile verrucous carci-
nomas studied by Varma et al"2 was positive
for HPV 16 or HPV 18. In the study by Villa
Table 3 Summary ofpublished data on penile verrucous and squamous cell carcinoma
associated HPV 16 and HPV 18 infections
Source Method Country HPV 16 HPV 18
Villa and Lopes, 1986 Southem blot Brazil 0/18 (0%) 7/18 (39%)
McCance, et al, 1986 Southem blot Brazil 26/53 (49%) 5/53 (9%)
Kiyabu, et al, 1989 PCR USA 2/5 (40%) 0/5 (0%)
Masih, et al, 1992 ISH USA 0/10 (0%) 0/10 (0%)
Varma, et al, 1992 PCR, ISH USA 12/18 (67%) 0/18 (0%)
Higgins, et al, 1992 ISH Australia 7/22 (32%) 0/22 (0%)
ISH Brazil 2/9 (22%) 0/9 (0%)
Wiener, et al, 1992 PCR USA 6/21 (29%) 1/21 (5%)
Present study PCR Hong Kong 4/41 (10%) 4/41 (10%)
ISH = in situ hybridisation; PCR = polymerase chain reaction.
and Lopes,9 there was one penile verrucous
carcinoma which was negative for HPV 16
and HPV 18. McCance et al'0 did not subclas-
sify the tumours in their series. Our study
showed that HPV DNA was present in three
(50%) of the poorly differentiated, and three
(18%) moderately differentiated squamous
cell carcinomas. Other studies have found a
high incidence of HPV 16 in grade 3 penile
intraepithelial neoplasia."
If HPV types 16 or 18 were responsible for
neoplastic transformation of penile carcino-
mas, irrespective of histological types and
grades, it seemed unlikely that viral DNA
should disappear from the better differenti-
ated tumours while being retained in the less
differentiated ones. The more likely explana-
tion is that different aetiological effectors were
operative in these different groups of penile
carcinomas. To support this view we found
the less differentiated and HPV positive penile
carcinomas in our series occurring in a signifi-
cantly older age group of patients than those
better differentiated tumours. Based on the
evidence accumulated so far, we concluded
that penile verrucous carcinomas were rarely, if
ever, associated with HPV types 16 and 18.
In summary, our study shows that HPV 16
and HPV 18 each infected 10% of penile car-
cinomas in Hong Kong. Infection by both
HPV types occurred in 5% of penile carcino-
mas. The incidence was very much lower than
that found in cervical carcinomas studied by
our laboratory. The older age of patients who
had penile carcinomas of higher grades and
the exclusive occurrence of HPV types 16 and
18 in this group of tumours suggest that the
better differentiated tumours, unlike the
higher grade tumours, were not associated
with HPV types 16 and 18. The absence of
HPV types 16 and 18 in penile verrucous car-
cinoma in our study and several others sug-
gested that there was no association between
these HPV types and penile verrucous carci-
noma. Further investigations are required to
find out whether penile carcinomas are associ-
ated with other HPV types.
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